NCT06142513

Brief Summary

Obesity Hypoventilation Syndrome(OHS) is a disease characterized by daytime hypercapnia and sleep-disordered breathing without other causes of hypoventilation in individuals with a body mass index above 30 kg/m2. Sources state that obesity is at the basis of the metabolic changes seen in individuals with OHS. Obesity, together with cardiovascular system complications, lung volumes, work of breathing and sleep quality, creating the basis for respiratory problems. In addition, sedentary lifestyle habits, which are common in obese individuals, cause negative effects on exercise capacity and peripheral muscle strength. It has been shown in the literature that decreased exercise capacity due to obesity strongly interacts with the risk of all-cause mortality. As a result of obesity and all this negative picture, impaired emotional state and decreased quality of life are observed in individuals. Numerous studies have shown that obese individuals generally have a low level of physical activity, there is a decrease in peripheral muscle strength, obese individuals are at risk for sleep-related respiratory problems and health-related quality of life is often negatively affected in obese individuals. With these studies, the effects of obesity on individuals have been evaluated with objective evaluation methods. However, the same cannot be said for OHS. It is not clear how exercise capacity, peripheral muscle strength and quality of life parameters, which are known to be negatively affected by obesity, are affected in individuals with OHS. Based on this point, this study aims to investigate whether OHS has an additional effect on exercise capacity, peripheral muscle strength and quality of life in addition to obesity.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
64

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Apr 2024

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 11, 2023

Completed
10 days until next milestone

First Posted

Study publicly available on registry

November 21, 2023

Completed
5 months until next milestone

Study Start

First participant enrolled

April 10, 2024

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2025

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2025

Completed
Last Updated

October 2, 2025

Status Verified

September 1, 2025

Enrollment Period

9 months

First QC Date

November 11, 2023

Last Update Submit

September 27, 2025

Conditions

Keywords

ObesityObesity Hypoventilation SyndromeExercise CapacityQuality of LifePeripheral Muscle Strength

Outcome Measures

Primary Outcomes (8)

  • Six Minute Walk Test-Distance

    The distance covered in meters in a straight corridor of 30 meters will be recorded as fast as possible but without running for 6 minutes.

    1 day

  • Six Minute Walk Test-Oxygen Saturation

    The 6-minute walk test is performed by walking as fast as possible for 6 minutes in a 30-meter corridor. Oxygen saturation measured by pulse oximetry before and after the test is recorded as a percentage.

    1 day

  • Six Minute Walk Test-Heart Rate

    The 6-minute walk test is performed by walking as fast as possible for 6 minutes in a 30-meter corridor. The heart rate measured by pulse oximetry is recorded before and after the test.

    1 day

  • Six Minute Walk Test-Blood Pressure

    The 6-minute walk test is performed by walking as fast as possible for 6 minutes in a 30-meter corridor. Before and after the test, blood pressure is measured with a sphygmomanometer and recorded in mmHg.

    1 day

  • Six Minute Walk Test-Dyspnea

    The 6-minute walk test is performed by walking as fast as possible for 6 minutes in a 30-meter corridor. Before and after the test, a score of 0-10 is recorded according to the Borg scale.

    1 day

  • Six Minute Walk Test-Leg Fatigue

    6 dakika yürüme testi, kişinin 30 metrelik bir koridorda 6 dakika boyunca mümkün olabilecek en hızlı şekilde yürümesi ile gerçekleştirilmektedir. Test öncesi ve sonrasında Borg skalasına göre 0-10 arasında puanlandırılarak kaydedilir.

    1 day

  • Nottingham Health Profile

    The Nottingham Health Profile (NHP) is a general patient reported outcome measure which seeks to measure subjective health status. It is a questionnaire designed to measure a patient's view of their own health status, in a number of areas. The NHP consists of two parts. The first part focuses on health and comprises 38 items which deal with pain, energy, sleep, mobility, emotional reaction and social isolation. The second part focuses on life areas affected and consists of 7 items which deal with problems regarding occupation, housework, social life, family life, sexual function, hobbies and holidays. The second part of the NHP is optional and can be omitted without ruining the test results.

    1 day

  • Muscle Strength - Dynamometer

    A digital dynamometer will be used to evaluate muscle strength. Muscle strength will be evaluated in the following muscles, each measurement will be made three times and the average will be taken.

    1 day

Secondary Outcomes (11)

  • Body Fat Percentage

    1 day

  • Body Fluid Percentage

    1 day

  • Muscle Mass

    1 day

  • Body Mass Index

    1 day

  • Anthropometric Measurements-Neck

    1 day

  • +6 more secondary outcomes

Study Arms (2)

Grup I

Subjects with obesity hypoventilation syndrome (30 \< body mass index \< 45 kg/m2)

Other: Assessment

Grup II

Age and sex-matched obese subjects (30 \< body mass index \< 45 kg/m2) with low risk of obstructive sleep apnea (STOP-BANG score \< 3)

Other: Assessment

Interventions

Between December 2023 and June 204, 46 volunteer participants aged 18 years and older who met the inclusion criteria and were followed up at Istanbul University, Istanbul Faculty of Medicine, Department of Chest Diseases and Istanbul Faculty of Medicine, Department of Internal Medicine were included in the project. Participants' body composition, comorbidities, exercise capacity, peripheral muscle strength, sleep quality and quality of life were assessed.

Grup IGrup II

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Patients with Obesity Hypoventilation Syndrome who are followed up in Istanbul University, Istanbul Faculty of Medicine, Department of Chest Diseases and obese individuals who are followed up in Istanbul University, Istanbul Faculty of Medicine, Department of Internal Diseases and who are in the low risk group according to stop bang evaluation will be included in the study.

You may qualify if:

  • \< body mass index \< 45 kg/m2
  • Patients who have been diagnosed with Obesity Hypoventilation Syndrome
  • Obese subjects with low risk of obstructive sleep apnea (STOP-BANG score \< 3)

You may not qualify if:

  • Patients with uncontrollable respiratory and comorbid diseases
  • Patient who have been an orthopedic, neurological, cardiac, or metabolic condition that may prevent participation and continuation of the exercise program throughout the study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Istanbul University-Cerrahpasa

Istanbul, 34320, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Obesity Hypoventilation SyndromeObesityHypoventilationRespiration DisordersSleep Wake Disorders

Interventions

Restraint, Physical

Condition Hierarchy (Ancestors)

Sleep Apnea, ObstructiveSleep Apnea SyndromesApneaRespiratory Tract DiseasesRespiratory InsufficiencySleep Disorders, IntrinsicDyssomniasNervous System DiseasesOverweightOvernutritionNutrition DisordersNutritional and Metabolic DiseasesBody WeightSigns and SymptomsPathological Conditions, Signs and SymptomsSigns and Symptoms, RespiratoryNeurologic ManifestationsMental Disorders

Intervention Hierarchy (Ancestors)

Behavior ControlTherapeuticsImmobilizationInvestigative Techniques

Study Officials

  • Goksen KURAN ASLAN, Assoc. Prof.

    Istanbul University - Cerrahpasa

    PRINCIPAL INVESTIGATOR
  • Ece ACIKBAS, PT,MSc

    Istanbul University - Cerrahpasa

    STUDY CHAIR
  • Ozge ERTAN HARPUTLU, PT,MSc

    Istanbul University - Cerrahpasa

    STUDY CHAIR
  • Esen KIYAN, Prof

    Istanbul University

    STUDY CHAIR
  • Bedia Fulya CALIKOGLU, Lect. PhD

    Istanbul University

    STUDY CHAIR

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associated Proffesor

Study Record Dates

First Submitted

November 11, 2023

First Posted

November 21, 2023

Study Start

April 10, 2024

Primary Completion

January 1, 2025

Study Completion

March 1, 2025

Last Updated

October 2, 2025

Record last verified: 2025-09

Data Sharing

IPD Sharing
Will not share

Locations